1. Implications of the GUSTO Trial for Thrombolytic Therapy

   • Frans Van de Werf

   Leading Article 31 October 2012 Pages: 307 - 312

2. In Vitro Fertilisation

   • Jenifer C. Jennings
   • Kimberly Moreland
   • C. Matthew Peterson

   Review Article 31 October 2012 Pages: 313 - 343

3. Aminoglycoside Administration as a Single Daily Dose

   • Fawziah Marra
   • Nilufar Partovi
   • Peter Jewesson

   Review Article 31 October 2012 Pages: 344 - 370

4. The Therapeutic Potential of Neuropeptide Y

   • Rajesh Munglani
   • Michael J. Hudspith
   • Stephen P. Hunt

   Review Article 31 October 2012 Pages: 371 - 389

5. Combination Antimicrobial Therapy for Bacterial Infections

   • Michael J. Rybak
   • Betty J. McGrath

   Disease Management 31 October 2012 Pages: 390 - 405

6. Quinupristin-Dalfopristin

   • Harriet M. Bryson
   • Caroline M. Spencer

   New Drug Profile 31 October 2012 Pages: 406 - 415

7. Quinupristin-Dalfopristin A Viewpoint

   • Roland Leclercq

   New Drug Profile 31 October 2012 Pages: 416 - 416

8. Quinupristin-Dalfopristin A Viewpoint

   • Caroline Johnson

   New Drug Profile 31 October 2012 Pages: 416 - 416

9. Remifentanil

   • Sanjay S. Patel
   • Caroline M. Spencer

   New Drug Profile 31 October 2012 Pages: 417 - 427

10. Remifentanil

    • Peter S. A. Glass

    New Drug Profile 31 October 2012 Pages: 428 - 428

11. Remifentanil

    • R. M. Jones

    New Drug Profile 31 October 2012 Pages: 428 - 428

12. Ropivacaine

    • Anthony Markham
    • Diana Faulds

    Drug Evaluation 31 October 2012 Pages: 429 - 449

13. Erratum to New hepatitis A vaccines and their role in prevention

    • D. B. Strader
    • L. B. Seeff

    Erratum 31 October 2012 Pages: 449 - 449

14. Moclobemide

    • Bret Fulton
    • Paul Benfield

    Drug Evaluation 31 October 2012 Pages: 450 - 474

15. Relief of Pain from Osseous Metastatic Lesions

    • Richard P. Spencer

    Correspondence 31 October 2012 Pages: 475 - 475